Otros idiomas Biomark Diagnostics Inc. Canadian Securities Exchange

Acciones

BUX

CA09073K1084

Mercado cerrado - Canadian Securities Exchange Otros sitios de cotización 20:20:17 17/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,24 ^CAD	-14,29 %		-2,04 %	-5,88 %

29/02	Biomark Diagnostics Inc. informa de los resultados del tercer trimestre y los nueve meses finalizados el 31 de diciembre de 2023	CI
28/02	BioMark Diagnostics Inc. se asocia con Rubix LS para avanzar en el cribado sanguíneo del cáncer en comunidades desatendidas	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Biomark Diagnostics : Announces Warrant Extension and Granting of Options	06/05
BioMark Announces Warrant Extension and Granting of Options	18/04
BioMark to Advance Development of Cancer Treatment for Glioblastoma	09/04
Biomark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	29/02
BioMark Diagnostics Inc. Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities	28/02
BioMark Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities	28/02
Biomark Diagnostics Inc. Appoints Theresa Peterson as Member of Advisory Team	26/02
Theresa Peterson Joins Biomark's Advisory Team	26/02
Biomark Diagnostics Closes $1.9 Million Non-Brokered Private Placement	29/12
BioMark Announces Closing of $1.9 Million Non-Brokered Private Placement	29/12
Biomark Diagnostics Inc. announced that it has received CAD 1.9 million in funding	29/12
BioMark Announces New Patent Granted in Canada For Liquid Biopsy Based Legacy Assay	04/12
BioMark Announces Recent New Patent Granted in Canada to Support Its Liquid Biopsy Based Legacy Assay	04/12
BioMark Provides Second Quarter Operational Update and Announces Extension to Warrant Exercise Term	28/11
Biomark Diagnostics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	28/11
BioMark Diagnostics Inc. Appoints Randolph Ford to its Strategic Advisory Team	14/11
BioMark Strengthens and Expands Its Strategic Advisory Team in Pursuit of Commercialization Initiatives	14/11
BioMark Announces Financial Contribution from the City of Quebec to Support Commercialization Initiatives of Its Proprietary Lung Cancer Detection Test	07/11
BioMark to Unveil Results of Its Early Breast Cancer Study at the Upcoming San Antonio Breast Cancer Symposium	24/10/23
Biomark Diagnostics : Une Technologie d’ici Pour Mieux Diagnostiquer le Cancer du Poumon – Local Technology for Improved Lung Cancer Diagnosis	10/09/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Biomark Diagnostics Inc. Canadian Securities Exchange

Acciones

BUX

CA09073K1084

Otros idiomas

Filtros